However, grades II and III tumors were recently defined as “lower-grade glioma,” considering that isocitrate dehydrogenase (IDH) mutations appear in most grade II and III gliomas but rarely in grade IV tumors [3]. Here, IDH3A is linked to central nervous system cancer.